Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Trubion Pharmaceuticals, Inc | v53941e10vq.htm |
| EX-10.4 - EXHIBIT 10.4 - Trubion Pharmaceuticals, Inc | v53941exv10w4.htm |
| EX-31.2 - EX-31.2 - Trubion Pharmaceuticals, Inc | v53941exv31w2.htm |
| EX-10.6 - EXHIBIT 10.6 - Trubion Pharmaceuticals, Inc | v53941exv10w6.htm |
| EX-31.1 - EX-31.1 - Trubion Pharmaceuticals, Inc | v53941exv31w1.htm |
| EX-10.1 - EXHIBIT 10.1 - Trubion Pharmaceuticals, Inc | v53941exv10w1.htm |
| EX-10.5 - EXHIBIT 10.5 - Trubion Pharmaceuticals, Inc | v53941exv10w5.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of TRUBION PHARMACEUTICALS, INC. on Form 10-Q for the
quarter ended September 30, 2009, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), each of the undersigned officers certifies, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects,
our financial condition and results of operations as of the dates and for the periods
expressed in the Report.
Date: November 5, 2009
| /s/ Peter A. Thompson, M.D., FACP | ||||
| Name: | Peter A. Thompson, M.D., FACP | |||
| Title: | President and Chief Executive Officer | |||
| /s/ Michelle G. Burris | ||||
| Name: | Michelle G. Burris | |||
| Title: | Senior Vice President and
Chief Financial Officer (Principal Accounting and Financial Officer) |
|||
41